NOBILIS CAV P4 VACCINE

País: Australia

Idioma: inglés

Fuente: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingredientes activos:

CHICKEN ANAEMIA VIRUS (LIVING, ATTENUATED) STRAIN 26P4

Disponible desde:

INTERVET AUSTRALIA PTY LIMITED

Designación común internacional (DCI):

CAV (live) - 26P4

formulario farmacéutico:

MISC. VACCINES OR ANTI SERA

Composición:

CHICKEN ANAEMIA VIRUS (LIVING, ATTENUATED) STRAIN 26P4 VACCINE-VIRAL Active 0.0 Undefined

Unidades en paquete:

1-25 vials; 1000 Doses; 50 vials; 500 Doses; Vials

clase:

VM - Veterinary Medicine

Fabricado por:

INTERVET AUSTRALIA

Grupo terapéutico:

CHICKEN PROGENY

Área terapéutica:

IMMUNOTHERAPY

indicaciones terapéuticas:

CAV DISEASE

Resumen del producto:

Poison schedule: 0; Withholding period: Zero (0) days. EXPORT SLAUGHTER INTERVA L(ESI): Zero (0) days. Before using this product, confirm the current ESI from I ntervet Australia Pty Limited on 1800 03 3 461 or the APVMA website (www.apvma.g ov.au/residues).; Host/pest details: CHICKEN PROGENY: [CAV DISEASE]; Poison schedule: 0; Withholding period: WHP: Nil; Host/pest details: CHICKEN PROGENY: [CAV DISEASE]; For protection of chicken progeny against chicken anaemia virus (CAV) disease by immunisation of breeders.

Estado de Autorización:

Registered

Fecha de autorización:

2023-07-01

Información para el usuario

Product Name:
APVMA Approval No:
NOBILIS CAV P4 VACCINE
58408-130888
Label Name:
NOBILIS CAV P4 VACCINE
Signal Headings:
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
Chicken Anaemia Virus living, attenuated strain 26P4. Minimum titre at
end of shelf-life 3.0
log10 TCID50 per dose.
Claims:
For protection of chicken progeny against Chicken Anaemia Virus (CAV)
disease by
immunisation of breeders.
Net Contents:
1 to 25, 50 vials of 500 Doses and 1000 Doses.
Directions for Use:
Restraints:
Contraindications:
Precautions:
Side Effects:
Dosage and
Administration:
USE ALL PRODUCT WITHIN 4 HOURS OF RECONSTITUTION.
MIX WELL BY GENTLE SHAKING.
Vaccinate healthy animals only.
For intramuscular (IM) or subcutaneous (SC) injection.
Reconstitute the vaccine in sterile Phosphate Buffered Saline (PBS)
Diluent. Select amount
of diluent to be used on number of doses per vial (200 mL per 1000
doses). Administer 0.2
mL of the vaccine by IM or SC injection. RLP APPROVED
General Directions:
Wash and disinfect hands and equipment after vaccinating.
Vaccination program
The optimum time and method of administration depend largely upon the
local situation.
Therefore, the advice of a veterinarian should be sought.
The vaccine can be administered to chickens from 6 weeks of age
onwards. To make sure
that adequate antibody levels are present at the onset of lay,
breeding stock has to be
vaccinated at least 6 weeks before this onset.
Immunity
The indication of high neutralising antibody levels is generally
dependent on the health and
condition of the birds. Hygiene and management are also important in
the post vaccination
period. Breeding stock have to be vaccinated by at least 6 weeks
before onset of lay. If
vaccination has been carried out correctly the protective antibody
level will be maintained
for at least one laying period.
Withholding Periods:
Zero (0) days.
Trade Advice:
EXPORT SLAUGHTER INTERVAL(ESI): Zero (0) days. Before using this
product, confirm
the current ESI from Intervet Australia Pty Limited on 1800 033 461 or
the APVM

Ficha técnica

PRODUCT NAME: INTERVET NOBILIS® CAV P4 VACCINE
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JULY, 2014
PAGE: 1 OF 6
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited (trading as MSD Animal
Health) Phone: [phone] (Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
Chicken Anaemia Virus (CAV) strain 26P4 (living, attenuated) in an
aqueous suspension
with stabilisers and buffering agents.
TRADE NAME:
INTERVET NOBILIS
® CAV P4 VACCINE
PRODUCT CODE:
3949
RECOMMENDED USE:
For the protection of chicken progeny against Chicken Anaemia Virus
disease by
immunisation of breeders.
APVMA NO:
58408
THIS VERSION ISSUED:
Is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S23, S37, S24/25. Do not breathe mists. Wear suitable gloves. Avoid
contact with skin and eyes.
SUSDP CLASSIFICATION:
None allocated.
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
Turbid liquid.
ODOUR:
Mild odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. However
product may be mildly
irritating, although unlikely to cause anything more than mild
transient discomfort.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
POTENTIAL HEALTH EFFECTS
EMERGENCY OVERVIEW
SECTION 2 - HAZARDS IDENTIFICATION
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
ISSUED BY: INTERVET AUSTRALIA PTY LIMITED
(TRADING AS MSD ANIMAL HEALTH)
91-105 HARPIN STREET
TEL: [phone] (BUSINESS HOURS)
BENDIGO EAST, VIC 3550, AUSTRALIA
FAX: [phone]
COMPANY ABN: 79 008 467 034
PRO